BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1741548)

  • 1. Role of platelet-activating factor in mediating tumor necrosis factor alpha-induced pulmonary vasoconstriction and plasma-lymph protein transport.
    Horvath CJ; Kaplan JE; Malik AB
    Am Rev Respir Dis; 1991 Dec; 144(6):1337-41. PubMed ID: 1741548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary vascular response to platelet-activating factor in awake sheep and the role of cyclooxygenase metabolites.
    Burhop KE; van der Zee H; Bizios R; Kaplan JE; Malik AB
    Am Rev Respir Dis; 1986 Sep; 134(3):548-54. PubMed ID: 3752711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
    Rabinovici R; Yue TL; Farhat M; Smith EF; Esser KM; Slivjak M; Feuerstein G
    J Pharmacol Exp Ther; 1990 Oct; 255(1):256-63. PubMed ID: 2213560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep.
    Christman BW; Lefferts PL; Blair IA; Snapper JR
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1272-8. PubMed ID: 2174655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor increases lung vascular permeability to protein.
    Burhop KE; Garcia JG; Selig WM; Lo SK; van der Zee H; Kaplan JE; Malik AB
    J Appl Physiol (1985); 1986 Dec; 61(6):2210-7. PubMed ID: 3804927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of WEB 2086 and SRI 63-441 on TNF-alpha-induced alterations in cardiopulmonary function.
    Kruse-Elliott KT; Dodam JR; Johnson LW; Olson NC
    Am J Physiol; 1992 Sep; 263(3 Pt 2):H761-70. PubMed ID: 1415600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin-induced leukopenia and thrombocytopenia are attenuated by PAF antagonist WEB 2086.
    van der Zee H; Moon DG; Kaplan JE; Gudewicz PW; Fenton J
    J Lab Clin Med; 1991 Apr; 117(4):305-12. PubMed ID: 1901342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cyclooxygenase products in lung injury induced by tumor necrosis factor in sheep.
    Wheeler AP; Hardie WD; Bernard GR
    Am Rev Respir Dis; 1992 Mar; 145(3):632-9. PubMed ID: 1546845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary microcirculatory responses to leukotrienes B4, C4 and D4 in sheep.
    Noonan TC; Kern DF; Malik AB
    Prostaglandins; 1985 Sep; 30(3):419-34. PubMed ID: 2997844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prostacyclin on pulmonary vascular response to thrombin in awake sheep.
    Perlman MB; Lo SK; Malik AB
    J Appl Physiol (1985); 1986 Feb; 60(2):546-53. PubMed ID: 3512510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin-induced alterations in lung fluid balance in awake sheep.
    Lo SK; Perlman MB; Niehaus GD; Malik AB
    J Appl Physiol (1985); 1985 May; 58(5):1421-7. PubMed ID: 3997709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
    Chang SW
    J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor: evidence against a role in hypoxic pulmonary vasoconstriction.
    McCormack DG; Barnes PJ; Evans TW
    Crit Care Med; 1990 Dec; 18(12):1398-402. PubMed ID: 2245615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte repletion reverses protective effect of neutropenia in thrombin-induced increase in lung vascular permeability.
    Lo SK; Garcia-Szabo RR; Malik AB
    Am J Physiol; 1990 Jul; 259(1 Pt 2):H149-55. PubMed ID: 2375401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-induced lung injury is not mediated by platelet-activating factor.
    Chang SW; Ohara N; Kuo G; Voelkel NF
    Am J Physiol; 1989 Oct; 257(4 Pt 1):L232-9. PubMed ID: 2801951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary transvascular fluid and protein exchange after thrombin-induced microembolism. Differential effects of cyclooxygenase inhibitors.
    Johnson A; Malik AB
    Am Rev Respir Dis; 1985 Jul; 132(1):70-6. PubMed ID: 3925828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibuprofen prevents thrombin-induced lung vascular injury: mechanism of effect.
    Perlman MB; Johnson A; Malik AB
    Am J Physiol; 1987 Mar; 252(3 Pt 2):H605-14. PubMed ID: 3030141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils.
    Horvath CJ; Ferro TJ; Jesmok G; Malik AB
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9219-23. PubMed ID: 3143114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
    Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR
    Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of thromboxane synthase inhibition on tumor necrosis factor-induced lung injury in sheep.
    Koizumi T; Kubo K; Kobayashi T; Sekiguchi M
    J Appl Physiol (1985); 1992 Aug; 73(2):618-24. PubMed ID: 1399989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.